| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $11.2B | $10.4B | $9.7B | $8.4B | $7.8B | $7.6B | $2.4B | $1.1B |
| Cost of Revenue | $7.4B | $7.0B | $6.7B | $5.8B | $5.5B | $5.4B | $5.9B | $3.1B |
| Gross Profit | $3.8B | $3.4B | $2.9B | $2.5B | $2.4B | $2.1B | $0.7B | $0.3B |
| R&D Expense | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.1B |
| SG&A Expense | $1.5B | $1.2B | $1.1B | $1.0B | $1.0B | $0.9B | $1.2B | $0.6B |
| Operating Income | $1.8B | $1.6B | $1.3B | $1.0B | $0.9B | $0.7B | $0.2B | $0.1B |
| Net Income | $1.2B | $1.1B | $0.8B | $0.6B | $0.6B | $0.4B | $0.1B | $0.0B |
| EPS (Basic) | $6.84 | $6.05 | $4.54 | $3.46 | $2.96 | $2.18 | $0.71 | $0.36 |
| EPS (Diluted) | $6.83 | $6.04 | $4.53 | $3.46 | $2.96 | $2.17 | $0.71 | $0.36 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $22.1B | $18.7B | $19.0B | $18.5B | $18.5B | $18.5B | $18.9B | $8.6B |
| Current Assets | $5.7B | $4.9B | $4.9B | $4.3B | $3.8B | $3.9B | $4.2B | $4.4B |
| Cash & Equivalents | — | — | — | — | $0.5B | $0.6B | $0.6B | $0.6B |
| Total Liabilities | $10.9B | $8.6B | $8.5B | $8.4B | $8.2B | $8.3B | $9.0B | $5.8B |
| Current Liabilities | $5.2B | $3.8B | $4.1B | $3.5B | $2.9B | $3.2B | $3.3B | $1.6B |
| Stockholders' Equity | $11.1B | $10.1B | $10.5B | $10.1B | $10.2B | $10.1B | $10.0B | $2.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.8B | $1.8B | $1.2B | $1.0B | $1.1B | $0.8B | $1.0B | $0.3B |
| Investing Cash Flow | $-2.7B | $-0.3B | $-0.5B | $-0.2B | $-0.5B | $-0.2B | $-3.2B | $-0.1B |
| Capital Expenditures | $0.3B | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B | $0.2B | $0.1B |
| Financing Cash Flow | $1.0B | $-1.4B | $-0.6B | $-0.7B | $-0.7B | $-0.6B | $0.5B | $2.0B |